Views

It’s time to get lenacapavir approved by NHS England and out to people who need it.

The AIDS Impact Conference in Casablanca explored HIV community-led and person-centered approaches amidst global funding cuts.

As NICE prepares a final decision on long-acting injectable PrEP cabotegravir, National AIDS Trust calls for its approval as a way to tackle inequalities and to end new HIV cases.

A prescription model will help to stop new cases and alleviate the pressures faced by many women with HIV.

30% of sexual health services in rural England don’t offer this postal service

Initiatives like HIV Testing Week increase our chances of stopping new HIV transmissions by 2030.

Daniel Fluskey, our Director of Policy, Research and Influencing takes a look back over what has been achieved in 2024, and what we still need to do as we head towards 2030.

Oluwakemi Agunbiade, our Senior Research & Policy Officer, writes about how health inequalities faced by Black people with and at risk of HIV are not new – and that is the problem.

James Cole, our Senior Policy, Research and Influencing Manager, write about how disengagement in HIV care is a global issue driven by inequalities and intersecting forms of stigma and discrimination.